If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 548.20
Bid: 546.40
Ask: 546.60
Change: 13.20 (2.47%)
Spread: 0.20 (0.037%)
Open: 536.60
High: 548.20
Low: 536.20
Prev. Close: 535.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Secondary Placing of Ordinary Shares

14 Jan 2022 07:00

RNS Number : 4148Y
Goldman Sachs International
14 January 2022
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OR THE SOLICITATION OF AN OFFER TO BUY IN ANY JURISDICTION, NOR SHALL THERE BE ANY SALE, OF THE SECURITIES REFERRED TO HEREIN IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SALES WOULD BE PROHIBITED BY APPLICABLE LAW.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

 

14 January 2022

 

PLACING OF 40 MILLION ORDINARY SHARES IN B&M EUROPEAN VALUE RETAIL S.A. ("B&M") BY SSA INVESTMENTS S.À R.L. ("SSA INVESTMENTS" or "SELLER")

 

SSA Investments announces that it has sold an aggregate of 40 million ordinary shares (the "Placing Shares") in B&M, representing approximately 4.0% of B&M's issued ordinary share capital, at a price of 585 pence per share (the "Placing") raising aggregate gross sale proceeds of £234 million.

 

Following settlement of the Placing, which is expected to take place on 18 January 2022, SSA Investments will continue to hold approximately 7.0% of B&M's ordinary shares.

 

Goldman Sachs International ("Goldman Sachs") acted as Sole Bookrunner in connection with the Placing. N. M. Rothschild & Sons Limited ("Rothschild & Co") has acted as the sole Financial Adviser to SSA Investments.

 

 

IMPORTANT NOTICE

 

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions), Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

 

The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by SSA Investments S.à r.l. or any of its respective affiliates that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

 

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and, subject to certain exemptions, may not be offered or sold in the United States (as defined in Regulation S under the Securities Act). Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

 

Members of the public are not eligible to take part in the Placing. This Announcement and the terms and conditions set out herein are for information purposes only and are directed at and may only be communicated to (a) in the European Economic Area ("EEA"), persons who are "qualified investors" within the meaning of Article 2(e) of Prospectus Regulation (Regulation (EU) 2017/1129); and (b) in the United Kingdom, at "qualified investors" within the meaning of Article 2(e) of the UK version of Prospectus Regulation (Regulation (EU) 2017/1129) which forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 who are also (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order; or (iii) persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons").

 

Any investment or investment activity to which this Announcement relates is only available to, and will be engaged in only with, Relevant Persons. Persons distributing this Announcement must satisfy themselves that is lawful to do so.

 

In connection with any offering of the Placing Shares, Goldman Sachs International and any of its affiliates acting as an investor for their own account may take up as a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. They do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

 

Goldman Sachs International which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, is acting on behalf of SSA Investments and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of its clients or for providing advice in relation to any offering of the Placing Shares. Goldman Sachs International will not regard any other person as its client in relation to the offering of the Placing Shares.

 

Rothschild & Co, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting for SSA Investments and no-one else in connection with the Placing. Rothschild & Co will not regard any other person as its client(s) in relation to the Placing and will not be responsible to any person(s) other than the Seller for providing protections afforded to clients of Rothschild & Co nor for providing financial advice in relation to the Placing, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

This announcement does not purport to identify or suggest the risks (direct or indirect) which may be associated with an investment in B&M or its shares.

 

This announcement includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and include statements regarding intentions, beliefs or current expectations. No assurances can be given that the forward-looking statements in this announcement will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIFLFSALSIVLIF
Date   Source Headline
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report
2nd Nov 202212:06 pmRNSConfirmation of timing of Interim Results
31st Oct 20229:23 amRNSAppointment of directors- Result of Meeting
18th Oct 20223:51 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSNotice of GM
15th Sep 20228:20 amRNSManagement Succession and Board Update
9th Sep 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20223:06 pmRNSDirector/PDMR Shareholding
31st Aug 20223:01 pmRNSTotal Voting Rights
18th Aug 20227:00 amRNSBoard Appointment and Retirement
5th Aug 20224:41 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSAppointment of Joint Corporate Broker
3rd Aug 202212:12 pmRNSTR1 Notification
29th Jul 202210:28 amRNSAGM Voting Results
14th Jul 202212:07 pmRNSBlock Listing Application
13th Jul 20223:48 pmRNSBlock listing Interim Review
5th Jul 20227:00 amRNSBoard appointment
29th Jun 20227:00 amRNSQ1 FY23 Trading Update
21st Jun 20227:00 amRNSAnnual Financial Report and Notice of AGM
16th Jun 20229:55 amRNSHolding(s) in Company
9th Jun 20221:17 pmRNSHolding(s) in Company
9th Jun 202212:16 pmRNSDirector/PDMR grant of options
8th Jun 20227:00 amRNSDirector/PDMR Notice
31st May 20227:01 amRNSFY22 Preliminary Results
31st May 20227:00 amRNSCEO Succession
22nd Apr 20227:00 amRNSCEO Succession Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.